Skip to main contentSkip to navigation
Sirius Investors

SHPH Stock: Shuttle Pharmaceuticals Holdings, Inc. Stock Price, Analysis & Insights

Get live SHPH stock price $0.44, comprehensive Shuttle Pharmaceuticals Holdings, Inc. stock analysis, charts, news, and expert forecast. Real-time SHPH stock data and investment insights.

0.44
1.68%Today
SHPHShuttle Pharmaceuticals Holdings, Inc. • NASDAQ Global Market • Healthcare
Market Cap
476.39K
Volume
105.73K
52W High
6.20
52W Low
0.38

Loading chart data...

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Overview

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, SHPH trades at $0.44 with a market capitalization of 476.39K . Over the past 52 weeks, SHPH has traded between $0.38 and $6.20 , with the current price positioned at approximately 1% of...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 476.39K
  • Current price: $0.44
  • 52-week range: $0.38 - $6.20
  • P/E ratio: 44.49

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Shuttle Pharmaceuticals Holdings, Inc., in conjunction with its subsidiary Shuttle Pharmaceuticals, Inc., is committed to the identification, advancement, and commercialization of pharmaceutical agents crafted to heighten the susceptibility of cancer...

Company Information

CEO
Christopher Robert Cooper
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
9

Contact Information

Address
One Research Court
Country
US

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 44.5)

Higher growth potential with elevated volatility (Beta: 1.22)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Shuttle Pharmaceuticals Holdings, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Shuttle Pharmaceuticals Holdings, Inc.
  • Investors should consider how Shuttle Pharmaceuticals Holdings, Inc. fits within their overall portfolio allocation
  • Premium valuation (P/E: 44.5) requires strong growth to justify

Market Cap

476.39K

P/E Ratio (TTM)

44.49

Beta

1.22

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.